Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Assessment of Atherosclerotic Plaque Characteristics Change by DCE-MRI With Alirocumab
NCT02992301Phase 4Unknown
- Sponsor
- Westside Medical Associates of Los Angeles
- Start
- Nov 2016
- Primary completion
- Nov 2019
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of alirocumab in atherosclerosis, hyperlipidemia, sponsored by Westside Medical Associates of Los Angeles. Status: unknown.
02
Drugs
alirocumab
03
Conditions
atherosclerosishyperlipidemia
Beyond the preview
Go deeper on NCT02992301.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02992301.